D-0089-2024 Class III Terminated

Recalled by Taro Pharmaceuticals Inc. — Brampton

Recall Details

Product Type
Drugs
Report Date
November 15, 2023
Initiation Date
November 6, 2023
Termination Date
August 27, 2024
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
11,196 bottles

Product Description

Hydrocortisone 1% and Acetic Acid 2% Otic Solution USP, 10ml dropper bottle, RX Only, Mfd. by: Taro Pharmaceuticals Inc. Brampton, Ontario, Canada LGT 1C, Dist. by: Taro Pharmaceuticals U.S.A., Inc. Hawthorne, NY 10532. NDC 51672-3007-1

Reason for Recall

Failed Impurities/Degradation Specifications:Out-of-Specification result for Hydrocortisone related impurity and slightly lower than the established level of the Hydrocortisone Assay obtained during stability testing.

Distribution Pattern

Nationwide in the USA

Code Information

Lot# AC86809, AC86812, Exp Date: 01/31/2024